clinical pharmacology

(redirected from Pharmacology, clinical)
Also found in: Encyclopedia.

clin·i·cal phar·ma·col·o·gy

the branch of pharmacology concerned with the pharmacology of therapeutic agents in the prevention, treatment, and control of disease in humans.

clinical pharmacology

The science that studies the characteristics, effects, properties, reactions and uses of drugs—especially their therapeutic effect in humans—including toxicology, safety, pharmacodynamics and pharmacokinetics.

clin·i·cal phar·ma·col·o·gy

(klini-kăl fahrmă-kolŏ-jē)
Branch of pharmacology concerned with the pharmacology of therapeutic agents.
References in periodicals archive ?
Each entry includes a full description of the herb, its actions and pharmacology, clinical trials, indications and usage, contraindications, precautions and adverse reactions, drug interactions, dosage, and literature.
The text description of each of 80 herbs is organized into seven parts: constituents, pharmacology, clinical studies, therapeutics, safety, regulatory status, and references.
It weaves between culture, physiology, pathology, pharmacology, clinical medicine, art, politics and religion.
With each herb, the text reviews the herb's origin, uses, pharmacology, clinical trials, adverse effects, interactions, cautions, preparations and doses, summary evaluation and a list of references.
The Women's Health Initiative (WHI) reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women during 5 years of treatment with conjugated equine estrogens (0.625 mg) combined with medroxyprogesterone acetate (2.5 mg) relative to placebo (see CLINICAL PHARMACOLOGY, Clinical Studies section in the full Prescribing Information).
The FDA said its decision followed a comprehensive review of ephedra's pharmacology, clinical studies of its safety and effectiveness, analysis of more than 16,000 adverse reactions among consumers and other reports.
Editorial for initial issues covers such topics as androgen treatment, behavior intervention for insulin treatment, diabetic complications, vitamin-D deficiency, ultrasound thyroid treatment, pharmacology, clinical advances and hormone therapy for children.
Most recently, Dr Chodakewitz spent over 20 years at Merck Research Laboratories,leading clinical pharmacology, clinical development and programme regulatory strategy, including senior vice president of late-stage global development and vice president of early-stage development.
[1] MD, PhD, National Retrovirus Reference Laboratory, University of Belgrade Faculty of Medicine, Belgrade, Serbia; [2] MD, PhD, Institute of Infective and Tropical Disease 'Dr Kosta Todorovic', Professor, School of Medicine, University of Belgrade, Bulevar oslobodjenja 16, 11000 Belgrade, Serbia; [3] MD, PhD, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Associate Professor, School of Medicine, University of Belgrade, Dr Subotica P.O.
The state-of-the-art research and development (R&D) facility at Cadila Pharmaceuticals is manned by more than three hundred and fifty scientists and engineers from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, phytochemistry and different disciplines of engineering.